Blue Owl Capital Holdings LP
Top Portfolio Positions
44 positions ·
$465,208,552 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
6,322,696 | $113,113,030 | 24.31% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
17,859,499 | $80,367,745 | 17.28% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
4,416,353 | $30,075,363 | 6.46% | |
| NCDL |
Nuveen Churchill Direct Lending Corp.
Financial Services
|
2,143,626 | $27,266,922 | 5.86% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
1,909,764 | $27,137,746 | 5.83% | |
| OBDC |
Blue Owl Capital Corp
Financial Services
|
2,045,070 | $22,618,474 | 4.86% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
1,005,929 | $20,450,536 | 4.40% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
2,941,525 | $15,560,667 | 3.34% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
5,089,015 | $13,333,219 | 2.87% | |
| HLLY |
Holley Inc.
Consumer Cyclical
|
4,236,888 | $13,007,246 | 2.80% |
Portfolio Trend
18 quarters · across all stocks
Holdings in AQST
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,593,917 | 1,347,932 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,391,500 | 525,000 | Shares | Defined | 2026-02-20 | |
| 2025-09-30 | $6,987,500 | 1,250,000 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,045,200 | 920,000 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,668,000 | 920,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,204,000 | 900,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,100,500 | 1,225,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,964,000 | 1,140,000 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $3,727,500 | 875,000 | Shares | Defined | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||